Skip to main content
SpringerLink
Log in

Symposium Knochenveränderungen bei malignen Tumoren

  • Conference paper
Verhandlungen der Deutschen Gesellschaft für innere Medizin

Part of the book series: Verhandlungen der Deutschen Gesellschaft für innere Medizin ((VDGINNERE,volume 89))

  • 24 Accesses

Zusammenfassung

Verlängerte Lebenszeiten und verbesserte Behandlungsmöglichkeiten für Tumorerkrankungen bringen es mit sich, daß paraneoplastische Phänomene wie Kalziumstoffwechselstörungen und Osteopathien häufiger zum Problem werden. Die aufmerksamer gewordenen Ärzte tragen dementsprechend Vorsorge, daß der Patient nicht durch derartige Komplikationen zusätzlich gefährdet wird.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Burkhardt E, Kistler HJ (1981) Hypercalciämie bei hospitalisierten Patienten. Schweiz Med Wochenschr 111: 2017–2023

    PubMed  CAS  Google Scholar 

  • Hickey RC, Samaan NA, Jackson GL (1981) Hypercalcemia in patients with breast cancer. Arch Surg 116: 545–552

    Article  PubMed  CAS  Google Scholar 

  • Lafferty FW (1966) Pseudohyperparathyreoidism. Medicine (Baltimore) 45: 247–253

    Article  CAS  Google Scholar 

  • McDonnell GD, Dunstan CR, Evans RA, Carter JN, Hills E, Wong SYP, Mcneil DR (1982) Quantitative bone histology in the hypercalcemia of malignant disease. J Clin Endocrinol Metab 55: 1066–1072

    Article  PubMed  CAS  Google Scholar 

  • Villalon AH, Tattersall HHN, Fox RM, Woods RL (1979) Hypercalcemia after tamoxifen for breast cancer: a sign of tumour response? Br Med J 2: 1329–1330

    Article  PubMed  CAS  Google Scholar 

References

  • Binstock ML, Mundy GR (1980) Effects of calcitonin and glucocorticoids in combination in hypercalcemia of malignancy. Ann Intern Med 93: 269–272

    PubMed  CAS  Google Scholar 

  • Dominguez JH, Mundy GR (1980) Monocytes mediate osteoclastic bone resorption by prostaglandin production. Calcif Tissue Int 31: 29–34

    Article  PubMed  CAS  Google Scholar 

  • Eilon G, Mundy GR (1978) Direct resorption of bone by human breast cancer cells in vitro. Nature 276: 726–728

    Article  PubMed  CAS  Google Scholar 

  • Mundy GR, Luben RA, Raisz LG, Oppenheim JJ, Buell DN (1974) Bone-resorbing activity in supernatants from lymphoid cell lines. N Engl J Med 290: 867–871

    Article  PubMed  CAS  Google Scholar 

  • Mundy GR, Raisz LG, Cooper RA, Schechter GP, Salmon SE (1974) Evidence for the secretion of an osteoclast stimulating factor in myeloma. N Engl J Med 291: 1041–1046

    Article  PubMed  CAS  Google Scholar 

  • Mundy GR, Shapiro JL, Bandelin JG, Canalis EM, Raisz LC (1976) Direct stimulation of bone resorption by thyroid hormones. J Clin Invest 58: 529–534

    Article  PubMed  CAS  Google Scholar 

  • Mundy GR, Altman AJ, Gondek M, Bandelin JG (1977) Direct resorption of bone by human monocytes. Science 196: 1109–1111

    Article  PubMed  CAS  Google Scholar 

  • Mundy GR, Rick ME, Turcotte R, Kowalski MA (1978) Pathogenesis of hypercalcemia in lymphosarcoma cell leukemia – Role of an osteoclast activating factor-like substance and mechanism of action for glucocorticoid therapy. Am J Med 65: 600–606

    Article  PubMed  CAS  Google Scholar 

  • Mundy GR, Varani J, Orr W, Gondek MD, Ward PA (1978) Resorbing bone is chemotactic for monocytes. Nature 275: 132–135

    Article  PubMed  CAS  Google Scholar 

  • Mundy GR, Cove DH, Fisken R (1980) Primary hyperparathyroidism: Changes in the pattern of clinical presentation. Lancet 1: 1317–1320

    Article  PubMed  CAS  Google Scholar 

  • Mundy GR, Raisz LG (1981) Disorders of bone resorption. In: Bronner F, Coburn JW (eds) Disorders of mineral metabolism, vol III. Academic Press, New York, pp 1–66

    Google Scholar 

  • Mundy GR, Martin TJ (1982) Hypercalcemia of malignancy — Pathogenesis and treatment. Metabolism 31: 1247–1277

    Article  PubMed  CAS  Google Scholar 

  • Mundy GR, Wilkinson R, Heath DA (1983) Comparative study of available medical therapy for hypercalcemia of malignancy. Am J Med 74: 421–432

    Article  PubMed  CAS  Google Scholar 

  • Orr W, Varani J, Gondek MD, Ward PA, Mundy GR (1979) Chemotactic response of tumor cells to products of resorbing bone. Science 203: 176–179

    Article  PubMed  CAS  Google Scholar 

  • Raisz LG, Luben RA, Mundy GR, Dietrich JW, Horton JE, Trummel CL (1975) Effect of osteoclast activating factor from human leukocytes on bone metabolism. J Clin Invest 56: 408–413

    Article  PubMed  CAS  Google Scholar 

  • Strumpf M, Kowalski MA, Mundy GR (1978) Effects of glucocorticoids on osteoclast-activating factor. J Lab Clin Med 92: 772–778

    PubMed  CAS  Google Scholar 

  • Yoneda T, Mundy GR (1979) Monocytes regulate osteoclast-activating factor production by releasing prostaglandins. J Exp Med 150: 338–350

    Article  PubMed  CAS  Google Scholar 

Literatur

  1. Bockman RS (1980) Hypercalcemia in malignancy. Clin Endocrinol Metab 9: 317–333

    Article  PubMed  CAS  Google Scholar 

  2. Raskin P, McClain CJ, Medsger TA (1973) Hypocalcemia associated with metastatic bone disease. Arch Intern Med 132: 539–543

    Article  PubMed  CAS  Google Scholar 

  3. Stewart AF, Horst R, Deftos LJ, Cadman EC, Lang R, Broadus AE (1980) Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups. N Engl J Med 303: 1377–1383

    Article  PubMed  CAS  Google Scholar 

  4. Salassa RM, Jowsey J, Arnaud CD (1970) Hypophosphatemic osteomalacia associated with “nonendocrine” tumors. N Engl J Med 283: 65–70

    Article  PubMed  CAS  Google Scholar 

  5. Williams SJ, Green M, Kerr IH (1977) Detection of bone metastases in carcinoma of bronchus. Br Med J 1: 1004

    Article  PubMed  CAS  Google Scholar 

  6. Galasko CSP (1977) Skeletal metastases and mammary cancer. Ann R Coll Surg Engl 50: 3–28

    Google Scholar 

  7. Drezner MK, Lebovitz HE (1978) Primary hyperparathyroidism in paraneoplastic hypercalcemia. Lancet 2: 1004–1006

    Article  Google Scholar 

  8. Hickey RC, Samaan NA, Jackson GL (1981) Hypercalcemia in patients with breast cancer. Osseous metastases, hyperplastic parathyroid tissue, or pseudo hyperparathyroidism? Arch Surg 116: 545–552

    Article  PubMed  CAS  Google Scholar 

  9. Benson RC, Riggs BL, Pickard BM, Arnaud CD (1974) Radioimmunoassay of parathyroid hormone in hypercalcemic patients with malignant disease. Am J Med 56: 821–826

    Article  PubMed  Google Scholar 

  10. Lilienfeld-Toal H v, Niederle N, Keck E (1981) Elevated immunoreactive parathyroid hormone (iPTH) in normocalcemic lung cancer. Clin Res 29: 424A

    Google Scholar 

  11. Lilienfeld-Toal H v, Niederle N (1983) Increased immunoreactive parathyroid hormone in lung cancer (submitted)

    Google Scholar 

  12. Franck H, Hartlapp JH, Lilienfeld-Toal H v (1982) Increased set-point of parathyroid secretion induced by chronic hypercalcemia of non parathyroid reason. Eur J Clin Invest (Suppl) 12: 69

    Article  Google Scholar 

  13. Seyberth HW, Segre GV, Morgan JL, Sweetman BJ, Potts JT, Oates JA (1975) Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N Engl J Med 293: 1278–1283

    Article  PubMed  CAS  Google Scholar 

  14. Brenner DE, Harvey HA, Lipton A, Demers L (1982) A study of prostaglandin E2, parathormone and response to indomethacin in patients with hypercalcemia of malignancy. Cancer 49: 556–561

    Article  PubMed  CAS  Google Scholar 

  15. Durie BGM, Salmon SE, Mundy GR (1981) Relation of osteoclast activating factor production to extent of bone disease in multiple myeloma. Br J Haematol 47: 21–30

    Article  PubMed  CAS  Google Scholar 

  16. Luben RA (1981) Evidence for the participation of osteoclast activating factor in disease processes in vivo. In: Cohn DV et al. (eds) Hormonal control of calcium metabolism. Excerpta Medica 315–321

    Google Scholar 

  17. Kukreja SC, Shemerdiak WP, Lad TE, Johnson PA (1980) Elevated nephrogenous cyclic AMP with normal serum parathyroid hormone levels in patients with lung cancer. J Clin Endocrinol Metab 51: 167–169

    Article  PubMed  CAS  Google Scholar 

Literatur

  • Braunstein EM (1980) Non-Hodgkin disease of bone: Radiographic correlation with the histological classification. Radiology 137: 643–646

    PubMed  CAS  Google Scholar 

  • Dominok GW, Knoch HG (1977) Knochengeschwülste und geschwulstähnliche Knochenerkrankungen. Fischer, Jena

    Google Scholar 

  • Freyschmidt J (1980) Knochenerkrankungen im Erwachsenenalter. Springer, Berlin Heidelberg New York

    Book  Google Scholar 

  • Spagnoli J, Gattoni F, Viganotti G (1982) Roentgenographic aspects of Non-Hodgkin-Lymphomas presenting with osseus lesions. Skeletal Radiol 8: 39–41

    Article  PubMed  CAS  Google Scholar 

  • Uehlinger E (1981) Sekundäre Knochengeschwülste. In: Schinz HR et al. (Hrsg) Lehrbuch der Röntgendiagnostik. Thieme, Stuttgart New York

    Google Scholar 

Literatur

  • Chabner BA, Johnson RE, Young RC, Canllos GP, Hubbard SP, Johnson SK, DeVita VT Jr (1976) Sequential nonsurgical and surgical staging of non-Hodgkin lymphoma. Ann Intern Med 85: 149–154

    PubMed  CAS  Google Scholar 

  • Chabner BA, Haskell CM, Canellos GP (1969) Destructive bone lesions in chronic granulocytic leukemia. Medicine (Baltimore) 48: 401–41

    CAS  Google Scholar 

  • Cortes EP, Holland JF, Wang IJ, Glidewell O (1975) Adriamycin (NSC-123127) in 87 patients with osteogenic sarcoma. Cancer Chemother Rep 6: 305–313

    Google Scholar 

  • Durie BGM, Salmon SE (1975) A clinical staging system for multiple myeloma. Cancer 36: 842–854

    Article  PubMed  CAS  Google Scholar 

  • Gilbert HA, Kagan AR (1976) Metastases: incidence, detection, and evaluation without histologic confirmation. In: Weiss L (ed) Fundamental aspects of metastasis. North Holland Publ. Comp., Amsterdam Oxford, pp 385–406

    Google Scholar 

  • Jaffe N (1972) Recent advances in the chemotherapy of metastatic osteogenic sarcoma. Cancer 30: 1627–1631

    Article  PubMed  CAS  Google Scholar 

  • Henderson ES (1977) Acute leukemia: general considerations. In: Williams WJ, Beutler E, Erslev AJ, Rundles RW (eds) Hematology, 2nd ed. McGraw-Hill, New York, pp 809–830

    Google Scholar 

  • Kyle RA (1975) Multiple myeloma. Review of 869 cases. Mayo Clin Proc 50: 29–40

    PubMed  CAS  Google Scholar 

  • Lohrmann HP, Adam W, Heymer B, Kubanek B (1973) Microangiopathic hemolytic anemia in metastatic carcinoma. Report of eight cases. Ann Intern Med 79: 368–375

    PubMed  CAS  Google Scholar 

  • Newcomer LN, Silverstein MB, Cadman EC, Farber LR, Bertino JR, Prosnitz LR (1982) Bone involvement in Hodgkin’s disease. Cancer 49: 338–342

    Article  PubMed  CAS  Google Scholar 

  • Ochs IJ, Freeman AI, Douglass HO Jr, Higby DS, Mindell ER, Sinks LF (1978) Cis-dichlorodiammine-platinum (II) in advanced osteogenic sarcoma. Cancer Treat Rep 62: 239–245

    PubMed  CAS  Google Scholar 

  • Pannuti F, Rossi AP, Marraro D, Strocchi E, Cricca A, Piana E, Pollutri E (1980) The natural history of cancer pain. In: Twycross RG, Ventafridda V (eds) The continuing care of terminal cancer patients. Pergamon Press, Oxford, pp 75–78

    Google Scholar 

  • Poppe H (1976) Röntgenologische Frühdiagnostik. Orthop Praxis 10: 933–938

    Google Scholar 

  • Pratt CB, Shanks EC, Hustu HO, Rivera G, Smith J, Mahesh Kumar AP (1977) Adjuvant multiple drug chemotherapy for osteogenic sarcoma of the extremity. Cancer 39: 51–57

    Article  PubMed  CAS  Google Scholar 

  • Rosen G, Murphy ML, Huvos AG, Gutierrez A, Marcove R (1976) Chemotherapy, en bloc resection and prosthetic bone replacement in the treatment of osteogenic sarcoma. Cancer 37: 1–11

    Article  PubMed  CAS  Google Scholar 

  • Rosen G, Huvos AG, Mosende C, Beattie EJ, Exelby PR, Caparros B, Marcove RC (1978) Chemotherapy and thoracotomy for metastatic osteogenic sarcoma. A model for adjuvant chemotherapy and the rationale for the timing of thoracic surgery. Cancer 41: 841–849

    Article  PubMed  CAS  Google Scholar 

  • Rosen G, Marcove RC, Caparros B, Nirenberg A, Kosloff C, Huvos AG (1979) Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery. Cancer 43: 2163–2177

    Article  PubMed  CAS  Google Scholar 

  • Rosen G, Caparros B, Nirenberg A, Marcove RC, Huvos AG, Kosloff C, Lane J, Murphy ML (1981) Ewing’s sarcoma: Ten-Year experience with adjuvant chemotherapy. Cancer 47: 2204–2213

    Article  PubMed  CAS  Google Scholar 

  • Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, Marcove RC, Lane JM, Mehta B, Urban C (1982) Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49: 1221–1230

    Article  PubMed  CAS  Google Scholar 

  • Schreml W, Merkle W, Heimpel H (1981) Medikamentöse Schmerztherapie bei Krebspatienten. Med Klin 76: 43–47

    PubMed  CAS  Google Scholar 

  • Schreml W (1983) Supportive Maßnahmen bei der internistischen Tumorbehandlung: Schmerztherapie. In: Drings P, Schreml W (Hrsg) Supportive Maßnahmen in der internistischen Tumorbehandlung. W. Zuckschwerdt Verlag, München

    Google Scholar 

  • Silverberg E (1982) Cancer statistics 1982. CA 32: 15–31

    PubMed  CAS  Google Scholar 

  • Sutow WW, Sullivan MP, Wilbur JR, Cangir A (1975) A study of adjuvant chemotherapy in osteogenic sarcoma. J Clin Pharmacol 7: 530–533

    Google Scholar 

  • Thomas LB, Forkner CE, Frei E, Byron EB, Stabenau JR (1961) The skeletal lesions of acute leukemia. Cancer 14: 608–621

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abt. Innere Medizin VI — Endokrinologie, Med. Poliklinik, Univ. Heidelberg, Deutschland

    R. Ziegler

  2. Dept. of Medicine/Endocrinology, The Univ. of Texas Health Science Center, San Antonio, Texas, USA

    G. R. Mundy

  3. Patholog. Inst., Univ. Heidelberg, Deutschland

    B. Krempien

  4. Med. Univ.-Klinik Venusberg, Bonn, Deutschland

    H. von Lilienfeld-Toal

  5. Radiolog. Klinik, Klinikum St.-Jürgen-Straße, Bremen, Deutschland

    J. Freyschmidt

  6. Abt. Innere Medizin III, Klinikum der Univ. Ulm, Deutschland

    W. Schreml

  7. Abt. für Innere Medizin VI, Med. Univ.-Klinik Heidelberg, Deutschland

    H. W. Minne

Authors
  1. R. Ziegler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. R. Mundy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Krempien
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. von Lilienfeld-Toal
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Freyschmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W. Schreml
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H. W. Minne
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Kliniken der Landeshauptstadt Wiesbaden, Wiesbaden, D-6200, Deutschland

    Bernhard Schlegel

Rights and permissions

Reprints and permissions

Copyright information

© 1983 J. F. Bergmann Verlag, München

About this paper

Cite this paper

Ziegler, R. et al. (1983). Symposium Knochenveränderungen bei malignen Tumoren. In: Schlegel, B. (eds) Verhandlungen der Deutschen Gesellschaft für innere Medizin. Verhandlungen der Deutschen Gesellschaft für innere Medizin, vol 89. J.F. Bergmann-Verlag. https://doi.org/10.1007/978-3-642-85456-9_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85456-9_25

  • Publisher Name: J.F. Bergmann-Verlag

  • Print ISBN: 978-3-8070-0335-1

  • Online ISBN: 978-3-642-85456-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation